DAVITA INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- DAVITA INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $181.48M, a 36.02% decline year-over-year.
- DAVITA INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $196.37M, a 61.51% decline year-over-year.
- DAVITA INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $274.48M, a 24.88% decline year-over-year.
- DAVITA INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $240.05M, a 41.15% decline year-over-year.
- DAVITA INC. payments for repurchase of common stock for fiscal 2025 was $1.31B, a 5.60% decline from fiscal 2024.
- DAVITA INC. payments for repurchase of common stock for fiscal 2024 was $1.39B, a 409.12% increase from fiscal 2023.
- DAVITA INC. payments for repurchase of common stock for fiscal 2023 was $272.22M, a 66.07% decline from fiscal 2022.
- DAVITA INC. payments for repurchase of common stock for fiscal 2022 was $802.23M, a 47.86% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $181.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $892.38M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $196.37M 10-Q · filed 2026-05-05 | $994.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $274.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.31B 10-K · filed 2026-02-11 |
| 2025-09-30 | $240.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.40B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $283.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.57B derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $510.16M 10-Q · filed 2026-05-05 | $1.65B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $365.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.39B 10-K · filed 2026-02-11 |
| 2024-09-30 | $407.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.29B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $361.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $884.83M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $250.96M 10-Q · filed 2025-05-12 | $523.18M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $272.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $272.22M 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $184.80M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $566.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $802.23M 10-K · filed 2025-02-13 |
| 2022-09-30 | $184.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.46B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $381.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.60B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $236.23M 10-Q · filed 2023-05-08 | $1.46B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $656.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.54B 10-K · filed 2024-02-14 |
| 2021-09-30 | $321.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | $1.31B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $244.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $1.70B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $316.25M 10-Q · filed 2022-05-05 | $1.45B derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $432.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.46B 10-K · filed 2023-02-22 |
| 2020-09-30 | $704.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.57B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $2.63B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $321.80M 10-Q · filed 2021-04-29 | $2.71B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $546.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $2.38B 10-K · filed 2022-02-11 |
| 2019-09-30 | $1.76B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.84B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $73.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $429.41M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-05 | $871.13M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $1.16B 10-K · filed 2021-02-12 |
| 2018-09-30 | $356.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.64B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $514.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $1.38B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $290.38M 10-Q · filed 2019-05-07 | $1.09B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $481.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $802.95M 10-K · filed 2020-02-21 |
| 2017-09-30 | $89.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $798.34M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $231.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.05B derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-03 | $822.90M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $476.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $1.10B 10-K · filed 2019-02-22 |
| 2016-09-30 | $345.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $786.72M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $740.75M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $274.93M 10-Q · filed 2017-05-02 | $754.80M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $165.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $549.93M 10-K · filed 2018-02-23 |
| 2015-09-30 | $300.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | |
| 2015-06-30 | $14.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | |
| 2015-03-31 | $70.06M 10-Q · filed 2016-05-04 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $323.35M 10-K · filed 2014-02-21 |
| 2011-09-30 | $32.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | |
| 2010-12-31 | $469.83M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $618.50M 10-K · filed 2013-03-01 |
| 2010-09-30 | $48.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | |
| 2009-12-31 | $92.27M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | $153.50M 8-K · filed 2012-07-06 |
| 2009-09-30 | $29.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $124.27M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $95.06M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $32.02M 10-Q · filed 2010-05-03 | |
| 2008-12-31 | $63.04M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $232.72M 10-K · filed 2011-02-25 |
| 2008-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | |
| 2007-12-31 | $6.35M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |